Press release
Peritoneal Dialysis Market to Hit $9.16 Billion by 2033 | Driven by ESRD and Home Dialysis Demand | DataM Intelligence
Market OverviewThe peritoneal dialysis market plays an increasingly vital role in the treatment of end-stage renal disease (ESRD), offering patients greater flexibility and autonomy compared to conventional in-center hemodialysis. Peritoneal dialysis (PD) utilizes the patient's peritoneum, the lining of the abdomen as a biological filter, enabling waste removal from the blood. This modality has seen expanding adoption globally due to its home-based convenience, reduced healthcare system strain, and improvements in clinical outcomes. According to DataM Intelligence, the Peritoneal Dialysis Market Size reached US$ 4.85 billion in 2024 and is expected to reach US$ 9.16 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/peritoneal-dialysis-market?rk
The key growth drivers fueling this robust expansion include a rising prevalence of ESRD, especially linked to diabetes and hypertension, combined with increasing preference for home dialysis and more technologically advanced automated peritoneal dialysis (APD) systems. Among segments, automated peritoneal dialysis (APD) is expected to record the fastest growth, driven by integration with remote patient monitoring tools that enhance adherence, reduce hospitalizations, and improve overall patient outcomes. Regionally, North America currently leads in market share, supported by well-established healthcare infrastructure, favorable reimbursement frameworks, and growing patient awareness.
Key Highlights from the Report
➤ Peritoneal Dialysis Market Size reached US$ 4.85 billion in 2024, projected to hit US$ 9.16 billion by 2033.
➤ Market to expand at a 7.5% CAGR during 2025-2033, driven by ESRD prevalence and home-dialysis adoption.
➤ Automated peritoneal dialysis (APD) segment leads growth, supported by digital and remote monitoring innovations.
➤ North America holds the dominant regional share due to reimbursement support and strong healthcare infrastructure.
➤ Growing prevalence of diabetes and hypertension continues to push demand for peritoneal dialysis worldwide.
➤ Increased investments in home-based care and telehealth platforms provide strong growth opportunities.
Market Segmentation
The peritoneal dialysis market can be segmented by treatment type, product type, and end-user, each of which plays a crucial role in shaping demand dynamics.
By treatment type, the market is divided into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). CAPD remains widely adopted because of its simplicity and the fact that it does not require a machine, making it suitable for patients in both advanced and resource-limited healthcare settings. On the other hand, APD is witnessing faster growth as it leverages automated machines (cyclers) that conduct dialysis exchanges, often overnight, thereby offering greater convenience, especially for working-age patients and those seeking improved quality of life. The increasing integration of APD systems with digital platforms and remote patient monitoring tools is further accelerating this segment's adoption globally.
When segmented by product type, the market encompasses peritoneal dialysis solutions, machines, catheters, and consumables such as bags, tubing, and connectors. Solutions form the backbone of the market since they are required for every exchange cycle, creating consistent recurring demand. Catheters and consumables also account for a significant share, with innovations focused on minimizing infection risks and improving ease of use. Meanwhile, the machines segment, primarily consisting of automated cyclers, is expanding at a steady pace due to the rising shift toward APD, as patients and providers prioritize convenience, safety, and enhanced clinical outcomes.
Based on end-user, the market is primarily classified into hospitals, dialysis centers, and homecare settings. Hospitals and dialysis centers currently play a leading role, especially for the initiation of treatment, patient education, and monitoring. However, homecare settings are expected to witness substantial growth throughout the forecast period, as patients increasingly prefer at-home therapies to reduce travel, lower costs, and gain independence. The growth of telehealth platforms and reimbursement policies supporting home-based therapies has further accelerated this transition, positioning homecare as one of the most attractive segments in the global peritoneal dialysis market.
Looking For A Detailed Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=peritoneal-dialysis-market
Regional Insights
North America: Leads the market due to advanced infrastructure, reimbursement frameworks, and higher PD awareness.
Europe: Stable growth supported by national dialysis programs and digital health adoption.
Asia-Pacific: Expected to witness the fastest CAGR, driven by high CKD prevalence in countries like India and China, coupled with government initiatives and improving affordability.
Latin America & Middle East/Africa: Gradual adoption, with infrastructure limitations and awareness gaps slowing uptake.
Market Dynamics
Market Drivers
The peritoneal dialysis market is primarily driven by the rising prevalence of end-stage renal disease (ESRD), which is strongly linked to the growing incidence of diabetes, hypertension, and aging populations worldwide. This has created a steady demand for effective renal replacement therapies. Additionally, there is an increasing preference for home-based dialysis treatments, as they offer greater flexibility and independence to patients compared to conventional in-center hemodialysis. Technological advancements, particularly in automated peritoneal dialysis (APD) systems and remote patient monitoring, are further boosting adoption by improving convenience, patient outcomes, and adherence to treatment regimens.
Market Restraints
Despite its growth potential, the market faces certain restraints. The risk of peritonitis and other infections associated with long-term catheter use remains a significant concern, discouraging some patients from adopting PD. Moreover, awareness and training levels in emerging regions are still limited, with hemodialysis being the more familiar and widely practiced treatment method. High dropout rates due to complications, inadequate support, or lack of proper follow-up care also pose challenges to sustained PD adoption in certain markets.
Market Opportunities
On the other hand, the market presents numerous opportunities for growth. The expansion of telehealth-enabled PD monitoring and digital platforms is creating new ways to improve patient care and adherence. Untapped emerging markets, characterized by a surge in ESRD cases and increasing healthcare spending, offer significant room for expansion. Furthermore, ongoing research and development in PD solutions and devices aimed at reducing infection risks and improving ease of use will likely enhance adoption rates, making the market increasingly attractive to both healthcare providers and patients.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/peritoneal-dialysis-market
Reasons to Buy the Report
✔ Market valuation and forecast (US$ 4.85B in 2024 → US$ 9.16B by 2033).
✔ Segmentation analysis by type, product, end-user, and region.
✔ Insights into drivers, restraints, and emerging opportunities.
✔ Competitive intelligence and profiles of top market players.
✔ Regional trends analysis, identifying fastest-growing markets.
Frequently Asked Questions (FAQs)
◆ How big is the peritoneal dialysis market in 2024?
◆ What is the projected CAGR of the peritoneal dialysis market during 2025-2033?
◆ Which region is expected to dominate the peritoneal dialysis industry?
◆ What are the key drivers boosting the global peritoneal dialysis market?
◆ Who are the leading companies in the peritoneal dialysis market?
Company Insights
Key players operating in the peritoneal dialysis market include:
• Baxter International
• Fresenius Medical Care AG
• B. Braun Medical Inc.
• BD (Becton, Dickinson and Company)
• Mozarc Medical Holding LLC
• Terumo Corporation
• Renax Biomedical Tech. Co., Ltd.
• Medionics
• MITRA
• Diener Precision Pumps Ltd.
Recent Developments:
Automated PD systems with remote patient management features are gaining traction worldwide.
North America's share continues to expand due to reimbursement support and telehealth integration.
Conclusion
The peritoneal dialysis market is entering a transformative era, supported by a projected growth from US$ 4.85 billion in 2024 to US$ 9.16 billion by 2033, at a steady 7.5% CAGR. The shift toward home-based dialysis, integration of APD with digital monitoring, and rising ESRD cases globally position this market for long-term growth. While infection risks and awareness gaps remain challenges, advances in device safety and expansion into emerging markets present strong opportunities.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peritoneal Dialysis Market to Hit $9.16 Billion by 2033 | Driven by ESRD and Home Dialysis Demand | DataM Intelligence here
News-ID: 4160140 • Views: …
More Releases from DataM Intelligence 4market Research LLP

United States Exocrine Pancreatic Insufficiency Treatment Market 2024-2031: Comp …
The Global Exocrine Pancreatic Insufficiency Treatment Market reached US$ 3.30 billion in 2023 and is expected to reach US$ 5.37 billion by 2031, growing at a CAGR of 6.4% during the forecast period 2024-2031.
Exocrine Pancreatic Insufficiency (EPI) is a condition where the pancreas fails to produce sufficient digestive enzymes, leading to malabsorption, nutrient deficiencies, and gastrointestinal issues. Treatments primarily involve pancreatic enzyme replacement therapy (PERT), dietary modifications, and adjunctive nutritional…

Herpes Labialis Drugs Market 2024-2031: Comprehensive Analysis of Antiviral Ther …
The global herpes labialis drugs market reached US$ 1.16 billion in 2023 and is expected to reach US$ 1.7 billion by 2031 growing with a CAGR of 4.8% during the forecast period 2024-2031.
Herpes labialis, commonly known as cold sores, is caused by the Herpes Simplex Virus-1 (HSV-1). Treatment options include antiviral drugs such as acyclovir, valacyclovir, famciclovir, and topical formulations, which help reduce symptoms, accelerate healing, and prevent recurrence. The…

United States Chronic Inflammatory Demyelinating Polyneuropathy Market 2024-2031 …
Chronic Inflammatory Demyelinating Polyneuropathy Market is valued at a significant CAGR during the forecast period (2024-2031).
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that leads to progressive weakness, numbness, and sensory impairment in the limbs. Current treatments include corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange (plasmapheresis), and emerging biologics. The market is expanding due to increasing disease awareness, advances in therapeutic options, early diagnosis, and growing adoption of patient-centric…

United States Varicella Zoster Infections Treatment Market 2024-2031: In-Depth A …
Global Varicella Zoster Infections Treatment Market reached US$ 1,799.42 million in 2023 and is expected to reach US$ 2,523.90 million by 2031, growing at a CAGR of 4.3% during the forecast period 2024-2031.
Varicella Zoster Virus (HHV-3) causes chickenpox (varicella) and shingles (herpes zoster). Treatments include antiviral drugs (acyclovir, valacyclovir, famciclovir), vaccines, and pain management therapies to prevent complications and manage symptoms. The market is growing due to increasing prevalence of…
More Releases for APD
Aminopropanediol (APD) Research:CAGR of 5.6% during the forecast period
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Aminopropanediol (APD)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
The…
LiDAR APD Market Size 2024 to 2031.
Market Overview and Report Coverage
LiDAR, which stands for Light Detection and Ranging, is a technology that uses laser beams to measure distances and create detailed 3D maps of the surroundings. APD, or Avalanche Photodiode, is a crucial component of LiDAR systems that helps in converting light signals into electrical signals for processing.
The LiDAR APD Market is expected to experience significant growth in the coming years, with a projected…
Global APD Avalanche Photodiode Market Research Report 2023-2029
APD Avalanche Photodiode (APD) is a highly sensitive semiconductor electronic device that exploits the photoelectric effect to convert light to electricity. APDs can be thought of as photodetectors that provide a built-in first stage of gain through avalanche multiplication. From a functional standpoint, they can be regarded as the semiconductor analog to photomultipliers. By applying a high reverse bias voltage, APDs show an internal current gain effect due to impact…
APD Avalanche Photodiode Market Size, Share, Development by 2023
APD Avalanche Photodiode (APD) is a highly sensitive semiconductor electronic device that exploits the photoelectric effect to convert light to electricity. APDs can be thought of as photodetectors that provide a built-in first stage of gain through avalanche multiplication. From a functional standpoint, they can be regarded as the semiconductor analog to photomultipliers. By applying a high reverse bias voltage, APDs show an internal current gain effect due to impact…
Avalanche Photodiode (Apd) Market
Avalanche Photodiode (Apd) Market During the forecast period, the global photodiode market is anticipated to expand at a CAGR of 7.3%. The market for photodiodes has been expanding steadily during the past few years. Over the next ten years, APD Avalanche photodiodes are anticipated to have considerable demand, driven by the expanding use of photodiodes in numerous applications, including industrial and medical imaging and the automotive industry.
Avalanche APD A photodiode…
APD (Avalanche Photodiode) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the APD (Avalanche Photodiode) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report reveals…